Breathe Well Live Well
|
Teva Highlights QNAZE(TM) HFA Phase III Data at the 2010 Annual Meeting of the …
MarketWatch (press release) The results, presented at the 2010 Annual Meeting of the American College of Allergy, Asthma & Immunology (ACAAI) in Phoenix, Ariz., showed that the … |
View full post on asthma – Google News
|
KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy …
MarketWatch (press release) Ecallantide for Treatment of Acute Attacks of Acquired C1 Esterase Inhibitor Deficiency — Nisha S. Patel, MD, Asthma Allergy & Pulmonary Associates, … KALBITOR(R) (ecallantide) Data Presented at the American College of Allergy … |
View full post on asthma – Google News
|
NexBio Presents Data at ACAAI 2010 Demonstrating Mechanism of Action for …
PR Newswire (press release) NexBio presented nonclinical data at ACAAI 2009 from studies in three animal models of asthma, demonstrating that DAS181 inhibits airway hyperreactivity … |
View full post on asthma – Google News
|
Clinical Data Reports Positive Results From Early-stage Trials Of Stedivaze In …
RTT News Currently available adenosine agonists must be used with caution or are contraindicated in patients with asthma and COPD. The findings support the potential … |
View full post on asthma – Google News
|
Clinical Data, Inc. Presents Data from Phase I Studies of Stedivaze(TM …
MarketWatch (press release) Currently available adenosine agonists must be used with caution or are contraindicated in patients with asthma and COPD. The findings, presented at the … Clinical Data Reveals Positive Results From Early-stage Trials Of Stedivaze … |
View full post on asthma – Google News
|
Glaxo, Theravance report Relovair safety data
BusinessWeek GlaxoSmithKline PLC and Theravance Inc. said Wednesday their lung disease and asthma drug Relovair met its goals in a mid-stage safety study. … GSK and Theravance announce combination ICS/LABA Phase II results in the … GlaxoSmithKline Reports Positive Results For Phase II Trial Of Relovair In … Theravance Announces Results From Phase II Study For Developmental Combination … |
View full post on asthma – Google News
|
New Data Shows 'Smart Growth' Can Cut 140 Premature Deaths and 105000 Asthma …
PR Newswire (press release) The American Lung Association data shows health benefits, including reduced asthma attacks and premature deaths linked to the Vision California "mixed … |
View full post on asthma – Google News
|
Theravance Announces Data From the RELOVAIR(TM) Program to Be Presented at the …
MarketWatch (press release) A total of 13 preclinical and clinical abstracts for RELOVAIR(TM) and its individual components in COPD and asthma were accepted by ERS for presentation, … |
View full post on asthma – Google News